Skip to main content
SpringerLink
Log in

Angiogenic potential of BM MSCs derived from patients with critical leg ischemia

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427–435.

    Article  PubMed  Google Scholar 

  2. Duong-Van-Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P et al. Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol 2008; 21: 837–846.

    Article  PubMed  Google Scholar 

  3. Dudley AC, Udagawa T, Melero-Martin JM, Shih SC, Curatolo A, Moses MA et al. Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood 2010; 116: 3367–3371.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615–1622.

    Article  PubMed  Google Scholar 

  5. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM . Mouse model of angiogenesis. Am J Pathol 1998; 152: 1667–1679.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Smadja DM, Bieche I, Silvestre JS, Germain S, Cornet A, Laurendeau I et al. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 2008; 28: 2137–2143.

    Article  CAS  PubMed  Google Scholar 

  7. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005; 66: 543–551.

    Article  CAS  PubMed  Google Scholar 

  8. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006; 24: 1620–1626.

    Article  PubMed  Google Scholar 

  9. Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M et al. Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med 2010; 153: 650–654.

    Article  PubMed  Google Scholar 

  10. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Lam FF et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010; 121: 1113–1123.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

C d’Audigier was supported by the Fondation pour la recherche medicale (FRM). We thank Kayle Shapiro for helpful comments and proofreading of our manuscript. This work was supported by research grants from AP-HP PHRC Optipec (03-034), Fondation pour la recherche medicale (FRM) and Fondation de France.

Author contributions: DMS designed the study, performed the research and wrote the letter. Cd’A, CLG, LM and BD performed the research. JSS designed research protocols. LDC prepared BM-MNCs. PG and JE designed the OPTIPEC study, harvested BM from CLI patients and wrote the letter.

Author information

Authors and Affiliations

  1. Université Paris Descartes, Sorbonne Paris Cité, Paris, France

    D M Smadja, C d'Audigier, C L Guerin, L Mauge, J-S Silvestre, P Gaussem & J Emmerich

  2. INSERM UMRS 765, Faculté de Pharmacie, Paris, France

    D M Smadja, C d'Audigier, C L Guerin, L Mauge, B Dizier, P Gaussem & J Emmerich

  3. AP-HP, Hôpital Européen Georges Pompidou, Service d'Hematologie Biologique, Paris, France

    D M Smadja, C d'Audigier, L Mauge & P Gaussem

  4. Vascular Biology Program and Surgery department, Children's Hospital, Harvard Medical School, Boston, MA, USA

    D M Smadja

  5. INSERM UMRS 970, Paris Cardiovascular Research Center—PARCC, Paris, France

    C L Guerin & J-S Silvestre

  6. AP-HP, Hôpital Necker, Service de Biothérapies, Paris, France

    L Mauge & L Dal Cortivo

  7. AP-HP, Hôpital Européen Georges Pompidou, Service de Médecine Vasculaire, Paris, France

    J Emmerich

Authors
  1. D M Smadja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C d'Audigier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C L Guerin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Mauge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Dizier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J-S Silvestre
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L Dal Cortivo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P Gaussem
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J Emmerich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D M Smadja.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smadja, D., d'Audigier, C., Guerin, C. et al. Angiogenic potential of BM MSCs derived from patients with critical leg ischemia. Bone Marrow Transplant 47, 997–1000 (2012). https://doi.org/10.1038/bmt.2011.196

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.196

  • Springer Nature Limited

This article is cited by

Search

Navigation